fda compounding semaglutide warning 2025 october issued 25 letters to telehealth companies for false and misleading claims about compounded GLP-1 products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of GLP-1 Medications – FDA Guidance

doi: 10.3322/caac.21660 2 GBD 2019 Colorectal Cancer Collaborators

At the same time, the study was relatively small, and more, larger studies are needed to determine with certainty how GLP-1 affects survival in colorectal cancer

The dosage comparison between retatrutide and tirzepatide shows that retatrutide achieves similar or superior outcomes at comparable or lower milligram doses

Nearly half of Americans are living with obesity, which is associated with more than 200 related health issues and diseases, including type 2 diabetes

PlexusDx requires no membership fees or insurance, is HSA/FSA eligible, and serves all 50 states